Tuzistra XR (chlorpheniramine / codeine) Drug Interactions
A total of 860 drugs (4830 brand and generic names) are known to interact with Tuzistra XR (chlorpheniramine / codeine).
- 279 major drug interactions (1777 brand and generic names)
- 575 moderate drug interactions (3035 brand and generic names)
- 6 minor drug interactions (18 brand and generic names)
Check for interactions with Tuzistra XR (chlorpheniramine / codeine)
Common medications checked in combination with Tuzistra XR (chlorpheniramine / codeine)
- Abilify MyCite (aripiprazole)
- Arava (leflunomide)
- Atarax (hydroxyzine)
- Coumadin (warfarin)
- Darvon Compound-65 (aspirin / caffeine / propoxyphene)
- Diflucan (fluconazole)
- Dilacor XR (diltiazem)
- enalapril
- Januvia (sitagliptin)
- Lorabid Pulvules (loracarbef)
- Methotrexate LPF Sodium (methotrexate)
- Pomalyst (pomalidomide)
- Procardia (nifedipine)
- Quillivant XR (methylphenidate)
- Rebetron (interferon alfa-2b / ribavirin)
- Remicade (infliximab)
- Sandimmune (cyclosporine)
- Tofranil (imipramine)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Vioxx (rofecoxib)
Tuzistra XR (chlorpheniramine / codeine) alcohol/food Interactions
There is 1 alcohol/food interaction with Tuzistra XR (chlorpheniramine / codeine)
Tuzistra XR (chlorpheniramine / codeine) disease Interactions
There are 20 disease interactions with Tuzistra XR (chlorpheniramine / codeine) which include:
- Anticholinergic Effects
- Impaired Gi Motility
- Infectious Diarrhea
- Liver Disease
- Prematurity
- Renal Dysfunction
- Acute Alcohol Intoxication
- Drug Dependence
- Hypotension
- Intracranial Pressure
- Respiratory Depression
- Asthma/Copd
- Cardiovascular
- Renal/Liver Disease
- Adrenal Insufficiency
- Biliary Spasm
- Hypothyroidism
- Seizure Disorders
- Urinary Retention
- Arrhythmias
See Also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No information available. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. Multum's information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill, knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2018 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.